Gavir 500mg (Ganciclovir Vials) 500mg

Gavir 500mg is an antiviral medication available in vial form, used to treat infections caused by certain viruses. It contains 500mg of ganciclovir per vial, designed for intravenous administration. This antiviral agent helps manage viral replication in susceptible patients.

Strength

500mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

United Biotech (P) Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gavir 500mg is primarily used to treat infections caused by cytomegalovirus (CMV) in immunocompromised patients, such as those with HIV/AIDS or transplant recipients. It may also be prescribed for other viral conditions as determined by a healthcare provider. This medication works by slowing the growth of the virus, helping the body fight the infection more effectively.

Side Effects

Gavir 500mg may help reduce symptoms associated with viral infections, such as fever or fatigue, by targeting the virus directly. Patients may experience improved clinical outcomes when the medication is used as part of a prescribed treatment plan. Individual responses can vary based on the underlying condition and overall health.

Precautions & Warnings

Gavir 500mg should be handled with care, following proper storage and disposal guidelines to ensure safety. It is important to keep the medication at room temperature and away from moisture or direct light. Always follow the instructions provided by a healthcare professional when using this medication.

Avoid Interactions

Gavir 500mg may interact with other medications, including certain drugs that affect the kidneys or bone marrow. Combining it with other antiviral or immunosuppressive agents could alter its effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

References

Frequently Asked Questions

Gavir 500mg is used to treat infections caused by cytomegalovirus (CMV) in immunocompromised patients.

Gavir 500mg is administered intravenously as directed by a healthcare professional.

Its use for other viral infections depends on a healthcare provider's assessment and prescription.

Contact your healthcare provider for guidance if a dose is missed; do not double the dose.

Common effects may include nausea or headache, but individual responses vary.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.